United States securities and exchange commission logo




                                                                                
                          May 3, 2024

       David Moss
       Chief Financial Officer
       INmune Bio, Inc.
       225 NE Mizner Blvd., Suite 640
       Boca Raton, FL 33432

                                                        Re: INmune Bio, Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed May 1, 2024
                                                            File No. 333-279036

       Dear David Moss:

              This is to advise you that we have not reviewed and will not 
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for 
acceleration. We remind you
       that the company and its management are responsible for the accuracy and 
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of 
action by the staff.

                                                        Please contact Daniel 
Crawford at 202-551-7767 with any questions.



                                                                                
                          Sincerely,

                                                                                
                          Division of Corporation Finance
                                                                                
                          Office of Life Sciences
       cc:                                              David Manno, Esq.